Metabolic health is the foundation of every other system in the body. The CureForge Endocrine, Metabolic & Hormonal Health Institute is the federation’s research engine for that foundation. Eleven specialized AI systems collaborate across incretin-axis combination optimization including glucagon-like-peptide-1, glucosedependent-insulinotropic-polypeptide, and amylin combination design, type-2 diabetes treatment optimization across the modern oral and injectable classes, obesity therapeutic design across the next-generation incretin-receptor agonist class, type-1 diabetes cell-therapy coordination, monogenic diabetes specialization coordinated with the rare-disease institute, thyroid biology, adrenal biology, continuous-glucose-monitor integration through edge-computing pipelines, the cardiometabolic-immune cross-axis coordinator, gestational diabetes coordination with the maternal institute, and adversarial review of every metabolic claim.
Value proposition: - Incretin axis combination design as next-generation metabolic therapy
- Continuous-glucose-monitor integration through edge-computing pipelines
- Cardiometabolic-immune cross-axis coordinated across the federation